APA (7th ed.) Citation

Saliba, F., Duvoux, C., Dharancy, S., Dumortier, J., Calmus, Y., Gugenheim, J., . . . Conti, F. (2022). Five‐year outcomes in liver transplant patients receiving everolimus with or without a calcineurin inhibitor: Results from the CERTITUDE study. Liver International, 42(11), 2513. https://doi.org/10.1111/liv.15396

Chicago Style (17th ed.) Citation

Saliba, Faouzi, et al. "Five‐year Outcomes in Liver Transplant Patients Receiving Everolimus with or Without a Calcineurin Inhibitor: Results from the CERTITUDE Study." Liver International 42, no. 11 (2022): 2513. https://doi.org/10.1111/liv.15396.

MLA (9th ed.) Citation

Saliba, Faouzi, et al. "Five‐year Outcomes in Liver Transplant Patients Receiving Everolimus with or Without a Calcineurin Inhibitor: Results from the CERTITUDE Study." Liver International, vol. 42, no. 11, 2022, p. 2513, https://doi.org/10.1111/liv.15396.